In this investigation of the possible causes of resistance of HCC to chemotherapeutic agents, the major finding was that BEZ235 enhances antitumor activity of sorafenib in HCC cells by inhibiting PI3K/AKT/mTOR and inducing autophagy (Figure 8). The gene discussed is MTOR; the disease is hepatocellular carcinoma.